{"id":10844,"date":"2020-09-30T17:51:17","date_gmt":"2020-09-30T12:21:17","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=10844"},"modified":"2022-08-16T09:50:23","modified_gmt":"2022-08-16T04:20:23","slug":"medical-marijuana-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials","title":{"rendered":"Conditions Medical Marijuana is Anticipated to be Prescribed in the Offing"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a13f21feb93e\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a13f21feb93e\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials\/#Chronic_Pain\" >Chronic Pain&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials\/#Cachexia\" >Cachexia&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials\/#Epilepsy\" >Epilepsy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials\/#Multiple_Sclerosis\" >Multiple Sclerosis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials\/#Anxiety\" >Anxiety&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials\/#Way_ahead\" >Way ahead<\/a><\/li><\/ul><\/nav><\/div>\n\n<p>Marijuana also referred to as cannabis, is always in debate for its benefits and detriments. In some countries, it is legal while in some countries it is considered as a recreational and harmful product, and its cultivation, trafficking, possession, and ingesting can lead to a fine or even imprisonment. However, along with the legalization debate, worldwide a number of parallel research is underway on the bio-medical applications of cannabis or cannabidiol (CBD) products.<\/p>\n\n\n\n<p>Over the years the clinical research and trial conducted around marijuana have produced many noteworthy results and researchers have found them as a very significant treatment option. Worldwide numerous clinical trials are going to evaluate the safety, and effectiveness of medical marijuana for a number of diseases. <strong>As of today some of the diseases and conditions for which the medical marijuana clinical trials are going on includes:<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-chronic-pain\"><span class=\"ez-toc-section\" id=\"Chronic_Pain\"><\/span><strong>Chronic Pain&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/chronic-and-acute-pain-market\">Chronic pain<\/a><\/strong> is a substantially undertreated disease, which hooks people on a slew of medications for its management. However, recent years have witnessed a soaring interest in cannabis for treating chronic pain owing to the perception of cannabis being safe, cost-effective and a decreased dependence on opioids for managing pain.&nbsp;<\/p>\n\n\n\n<p>At present, the <a href=\"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-market\" target=\"_blank\" rel=\"noreferrer noopener\">medical marijuana market<\/a> is experiencing several pharma players exploring the safety and efficacy of medical marijuana to address chronic pain. GW Pharmaceuticals, Otsuka Pharmaceuticals, Aurora Cannabis, and Pfizer have been interested in exploring cannabis for pain management. GW Pharmaceuticals, a few months back, expressed its desire to commercialize its drug derived from cannabis extracts Nabiximols, also known as Sativex,\u00a0 in early 2021, which is right now undergoing Phase III clinical trials. Further, Aurora Cannabis is investigating a formulated whole-plant cannabis oil extract, MRCP001, as an add-on therapy to current treatment regimens for chronic pain in the Phase II stage of development (COPE &#8211; NCT03522467). Earlier this year, Aurora announced the purchase of a US-based CBD company, Reliva with an intention to carve out its presence in the American medical marijuana market.\u00a0<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-cachexia\"><span class=\"ez-toc-section\" id=\"Cachexia\"><\/span><strong>Cachexia&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/cancer-cachexia-pipeline-therapies\" target=\"_blank\" rel=\"noreferrer noopener\">Cachexia<\/a> often called cancer cachexia, is a wasting syndrome that results in weight loss, weakness, loss of appetite, and fatigue. Worldwide, a number of companies such as Tetra Bio-Pharma, MedQualis, Cannabics Pharmaceuticals Inc., GlaxoSmithKline, Parexel, and others are working in developing <a href=\"https:\/\/www.delveinsight.com\/blog\/marijuana-as-a-treatment-approach\" target=\"_blank\" rel=\"noreferrer noopener\">marijuana-based therapies <\/a>that can relieve cachexia symptoms.\u00a0<\/p>\n\n\n\n<p>Currently, Tetra Bio-Pharma in collaboration with MedQualis is investigating its drug <strong>PPP011<\/strong> (which is right now Phase 3). Another pharma giant, GlaxoSmithKline in collaboration with Parexel is also evaluating their Interventional drug GSK2881078 (currently in phase 2 testing). GSK-2881078, which is a selective androgen receptor modulator (SARM) might prove to be a potential treatment for cachexia.&nbsp;<\/p>\n\n\n\n<p>Ahead of all, Cannabics Pharmaceuticals, one of the leading personalized cannabinoid medicine companies, had completed the study for Cannabics Dosage-Controlled capsules for the treatment of cancer anorexia-cachexia syndrome (CACS) in advanced cancer patients. The company is now looking forward to exploring the research and commercial opportunity for its drugs.&nbsp;<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"895\" height=\"1024\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/01123709\/medical-marijuana-clinical-trials-chart-895x1024.jpg\" alt=\"medical-marijuana-clinical-trials-chart\" class=\"wp-image-10872\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/01123709\/medical-marijuana-clinical-trials-chart-895x1024.jpg 895w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/01123709\/medical-marijuana-clinical-trials-chart-262x300.jpg 262w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/01123709\/medical-marijuana-clinical-trials-chart-768x879.jpg 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/01123709\/medical-marijuana-clinical-trials-chart.jpg 930w\" sizes=\"(max-width: 895px) 100vw, 895px\" \/><figcaption>Medical Marijuana Clinical Trials<\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-epilepsy\"><span class=\"ez-toc-section\" id=\"Epilepsy\"><\/span><strong>Epilepsy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/epilepsy-market\" target=\"_blank\" rel=\"noreferrer noopener\">Epilepsy<\/a>, a central nervous system disorder, affects the normal functioning of the brain, causes seizures, and unusual behavior in the affected individual. The exploration of the marijuana in the epileptic patients can be attributed to the inclination of the patients affected with seizures reporting efficacy of marijuana in controlling seizures and mood disorders.<\/p>\n\n\n\n<p><strong>Tilray<\/strong>, a Canada-based pharmaceutical and cannabis company, is working in collaboration with the Hospital for Sick Children to test their potential drug <strong>TIL-TC150<\/strong> for drug resistant epilepsy due to Dravet syndrome. To assess dosing and tolerability of CBD-rich cannabis extract (TIL-TC150), Tilray is conducting Phase 1 clinical trial (NCT02983695) of the drug, which is expected to be completed by 2021.<\/p>\n\n\n\n<p>The other potential drug for epilepsy is in process by MGC Pharmaceuticals. MGC is testing the safety and efficacy of its durg MGCND00EP1, which is Phase 2 trial, is expected to act as an <em>add-on treatment <\/em>in children and adolescents with resistant epilepsies.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-multiple-sclerosis\"><span class=\"ez-toc-section\" id=\"Multiple_Sclerosis\"><\/span><strong>Multiple Sclerosis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Marijuna is also in demand in the <strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/multiple-sclerosis-market\">Multiple sclerosis<\/a><\/strong> space. To find an effective treatment for Multiple Sclerosis, companies such as Almirall, S.A., and GW Pharmaceuticals Ltd. are exploring the potential of marijuana. Multiple Sclerosis, a long-lasting disease, attacks the brain and spinal cord (central nervous system). Cannabis sativa (marijuana plant), contains chemicals that can affect the mind and body.&nbsp;<\/p>\n\n\n\n<p>GW Pharmaceuticals appears keenly interested in exploiting marijuana for medicinal purposes. The company is conducting the phase 3 study of <strong>Nabiximols &#8211; <\/strong>oromucosal spray (NCT04203498) as an add-on therapy for spasticity due to multiple sclerosis. The drug, also known as Sativex, is in trials for other conditions including PTSD, Spinal cord injury spasticity. Although Sativex is approved in many European and South American countries along with Canada, Israel, and Australia, it is currently not approved in the USA.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-anxiety\"><span class=\"ez-toc-section\" id=\"Anxiety\"><\/span><strong>Anxiety&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/generalized-anxiety-disorder-gad-market\">Anxiety disorders<\/a><\/strong> affect a significant population worldwide. It is characterised by feelings of fear, dread, worry, stress and uneasiness. A significant number of research is going on to treat Anxiety through marijuana.&nbsp;<\/p>\n\n\n\n<p>McMaster University and Tilray are jointly working on cannabidiol treatment for <strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/general-anxiety-disorder-gad-pipeline-insight\">anxiety disorders<\/a><\/strong> along with social anxiety disorder, panic disorder, and agoraphobia. The study of the Cannabidiol (CBD) Oil Capsules (NCT03549819) is in Phase III trials for the treatment of DSM-5 anxiety disorders.&nbsp;<\/p>\n\n\n\n<p>In another study, the University of Colorado, Denver in collaboration with GW Research had completed the study of tolerability and efficacy of Cannabidiol (GWP42003) in addressing tremors associated with Parkinson&#8217;s Disease. The GWP42003-P oral solution is found to be relatively safe and reduces tremor, anxiety in Parkinson&#8217;s Disease.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-way-ahead\"><span class=\"ez-toc-section\" id=\"Way_ahead\"><\/span>Way ahead<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Apart from these, a significant number of studies are going on to access the impact of medical marijuana on Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Huntington&#8217;s Disease, Irritable Bowel Syndrome, Schizophrenia, Psychosis, Glaucoma, and so many others. Medical marijuana has become a hot topic nowadays. However, the positive results and quite a sizable amount of investment in medical marijuana might gleam eyes, there are hurdles that hinder the growth of the medical marijuana market in the form of authority approvals, availability of marijuana, and large-scale clinical evidence.&nbsp;<\/p>\n\n\n\n<p>Even so, several jurisdictions have legalized the use of cannabis. Owing to the scope of legal clearance from other governments, increasing social acceptance, commercialization and business opportunity, an increasing number of clinical trials, and the wide range of therapeutic uses that cannabis can offer, in the coming years the <a href=\"https:\/\/www.delveinsight.com\/report-store\/medical-marijuana-market\" target=\"_blank\" rel=\"noreferrer noopener\">medical marijuana market<\/a> is expected to gain the attraction of other pharmaceutical and biotech companies.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Marijuana also referred to as cannabis, is always in debate for its benefits and detriments. In some countries, it is legal while in some countries it is considered as a recreational and harmful product, and its cultivation, trafficking, possession, and ingesting can lead to a fine or even imprisonment. However, along with the legalization debate, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":10871,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[3073,16697,16698,16336],"industry":[17225],"therapeutic_areas":[17245,18720,17228,17234],"class_list":["post-10844","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-medical-marijuana","tag-medical-marijuana-clinical-trials","tag-medical-marijuana-companies","tag-medical-marijuana-market","industry-pharmaceutical","therapeutic_areas-neurology","therapeutic_areas-nutritional-disorders-and-weight-loss","therapeutic_areas-oncology","therapeutic_areas-rare-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Clinical Trials Exploring Medical Marijuana | Medical Marijuana Market<\/title>\n<meta name=\"description\" content=\"Several companies are running clinical trials to explore the Medical Marijuana in diseases like Epilepsy, Cachexia, Chronic pain, Anxiety...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Trials Exploring Medical Marijuana | Medical Marijuana Market\" \/>\n<meta property=\"og:description\" content=\"Several companies are running clinical trials to explore the Medical Marijuana in diseases like Epilepsy, Cachexia, Chronic pain, Anxiety...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-30T12:21:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-16T04:20:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/09\/01123626\/medical-marijuana-clinical-trials.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"772\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Clinical Trials Exploring Medical Marijuana | Medical Marijuana Market","description":"Several companies are running clinical trials to explore the Medical Marijuana in diseases like Epilepsy, Cachexia, Chronic pain, Anxiety...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials","og_locale":"en_US","og_type":"article","og_title":"Clinical Trials Exploring Medical Marijuana | Medical Marijuana Market","og_description":"Several companies are running clinical trials to explore the Medical Marijuana in diseases like Epilepsy, Cachexia, Chronic pain, Anxiety...","og_url":"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2020-09-30T12:21:17+00:00","article_modified_time":"2022-08-16T04:20:23+00:00","og_image":[{"width":772,"height":482,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/09\/01123626\/medical-marijuana-clinical-trials.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials","url":"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials","name":"Clinical Trials Exploring Medical Marijuana | Medical Marijuana Market","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/09\/01123626\/medical-marijuana-clinical-trials.jpg","datePublished":"2020-09-30T12:21:17+00:00","dateModified":"2022-08-16T04:20:23+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Several companies are running clinical trials to explore the Medical Marijuana in diseases like Epilepsy, Cachexia, Chronic pain, Anxiety...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-clinical-trials#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/09\/01123626\/medical-marijuana-clinical-trials.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/09\/01123626\/medical-marijuana-clinical-trials.jpg","width":772,"height":482,"caption":"medical-marijuana-clinical-trials"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/09\/01123626\/medical-marijuana-clinical-trials-300x187.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Medical marijuana<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Medical marijuana clinical trials<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Medical marijuana companies<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Medical Marijuana Market<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Medical marijuana<\/span>","<span class=\"advgb-post-tax-term\">Medical marijuana clinical trials<\/span>","<span class=\"advgb-post-tax-term\">Medical marijuana companies<\/span>","<span class=\"advgb-post-tax-term\">Medical Marijuana Market<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 6 years ago","modified":"Updated 4 years ago"},"absolute_dates":{"created":"Posted on Sep 30, 2020","modified":"Updated on Aug 16, 2022"},"absolute_dates_time":{"created":"Posted on Sep 30, 2020 5:51 pm","modified":"Updated on Aug 16, 2022 9:50 am"},"featured_img_caption":"medical-marijuana-clinical-trials","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/10844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=10844"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/10844\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/10871"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=10844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=10844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=10844"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=10844"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=10844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}